Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 108

1.

Effects of chimeric decoy oligodeoxynucleotide in the regulation of transcription factors NF-κB and Sp1 in an animal model of atherosclerosis.

Lee WR, Kim KH, An HJ, Park YY, Kim KS, Lee CK, Min BK, Park KK.

Basic Clin Pharmacol Toxicol. 2013 Apr;112(4):236-43. doi: 10.1111/bcpt.12029. Epub 2012 Dec 6.

PMID:
23107157
[PubMed - indexed for MEDLINE]
2.

Effect of NF-κB decoy oligodeoxynucleotide on LPS/high-fat diet-induced atherosclerosis in an animal model.

Kim SJ, Park JH, Kim KH, Lee WR, Lee S, Kwon OC, Kim KS, Park KK.

Basic Clin Pharmacol Toxicol. 2010 Dec;107(6):925-30. doi: 10.1111/j.1742-7843.2010.00617.x.

PMID:
20649557
[PubMed - indexed for MEDLINE]
3.

The inhibitory effect of chimeric decoy oligodeoxynucleotide against NF-κB and Sp1 in renal interstitial fibrosis.

Kim KH, Park JH, Lee WR, Park JS, Kim HC, Park KK.

J Mol Med (Berl). 2013 May;91(5):573-86. doi: 10.1007/s00109-012-0972-2. Epub 2012 Nov 1. Erratum in: J Mol Med (Berl). 2013 Jul;91(7):901-2.

PMID:
23114611
[PubMed - indexed for MEDLINE]
4.

Transcriptional regulation of NF-kappaB by ring type decoy oligodeoxynucleotide in an animal model of nephropathy.

Kim KH, Lee ES, Cha SH, Park JH, Park JS, Chang YC, Park KK.

Exp Mol Pathol. 2009 Apr;86(2):114-20. doi: 10.1016/j.yexmp.2008.11.011. Epub 2008 Dec 11.

PMID:
19118545
[PubMed - indexed for MEDLINE]
5.

Antifibrotic effect of synthetic Smad/Sp1 chimeric decoy oligodeoxynucleotide through the regulation of epithelial mesenchymal transition in unilateral ureteral obstruction model of mice.

Sung WJ, Kim KH, Kim YJ, Chang YC, Lee IH, Park KK.

Exp Mol Pathol. 2013 Oct;95(2):136-43. doi: 10.1016/j.yexmp.2013.06.008. Epub 2013 Jun 17.

PMID:
23791891
[PubMed - indexed for MEDLINE]
6.

Prevention of abdominal aortic aneurysms by simultaneous inhibition of NFkappaB and ets using chimeric decoy oligonucleotides in a rabbit model.

Miyake T, Aoki M, Nakashima H, Kawasaki T, Oishi M, Kataoka K, Tanemoto K, Ogihara T, Kaneda Y, Morishita R.

Gene Ther. 2006 Apr;13(8):695-704.

PMID:
16397509
[PubMed - indexed for MEDLINE]
7.

Inhibition of experimental abdominal aortic aneurysm in the rat by use of decoy oligodeoxynucleotides suppressing activity of nuclear factor kappaB and ets transcription factors.

Nakashima H, Aoki M, Miyake T, Kawasaki T, Iwai M, Jo N, Oishi M, Kataoka K, Ohgi S, Ogihara T, Kaneda Y, Morishita R.

Circulation. 2004 Jan 6;109(1):132-8. Epub 2003 Dec 8.

PMID:
14662712
[PubMed - indexed for MEDLINE]
Free Article
8.

Antifibrotic effect through the regulation of transcription factor using ring type-Sp1 decoy oligodeoxynucleotide in carbon tetrachloride-induced liver fibrosis.

Park JH, Jo JH, Kim KH, Kim SJ, Lee WR, Park KK, Park JB.

J Gene Med. 2009 Sep;11(9):824-33. doi: 10.1002/jgm.1355.

PMID:
19554625
[PubMed - indexed for MEDLINE]
9.

Alpha-lipoic acid attenuates atherosclerotic lesions and inhibits proliferation of vascular smooth muscle cells through targeting of the Ras/MEK/ERK signaling pathway.

Lee WR, Kim A, Kim KS, Park YY, Park JH, Kim KH, Kim SJ, Park KK.

Mol Biol Rep. 2012 Jun;39(6):6857-66. doi: 10.1007/s11033-012-1511-5.

PMID:
22302393
[PubMed - indexed for MEDLINE]
10.

Selective inactivation of NF-kappaB in the liver using NF-kappaB decoy suppresses CCl4-induced liver injury and fibrosis.

Son G, Iimuro Y, Seki E, Hirano T, Kaneda Y, Fujimoto J.

Am J Physiol Gastrointest Liver Physiol. 2007 Sep;293(3):G631-9. Epub 2007 Jul 19.

PMID:
17640975
[PubMed - indexed for MEDLINE]
Free Article
11.

Effects of intratracheal administration of nuclear factor-kappaB decoy oligodeoxynucleotides on long-term cigarette smoke-induced lung inflammation and pathology in mice.

Li YT, He B, Wang YZ, Wang J.

Respir Res. 2009 Aug 25;10:79. doi: 10.1186/1465-9921-10-79.

PMID:
19706153
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Intravenous injection of oligodeoxynucleotides to the NF-kappaB binding site inhibits hepatic metastasis of M5076 reticulosarcoma in mice.

Kawamura I, Morishita R, Tsujimoto S, Manda T, Tomoi M, Tomita N, Goto T, Ogihara T, Kaneda Y.

Gene Ther. 2001 Jun;8(12):905-12.

PMID:
11426330
[PubMed - indexed for MEDLINE]
Free Article
13.

A decoy oligonucleotide to NF-κB delivered through inhalable particles prevents LPS-induced rat airway inflammation.

De Stefano D, Coletta C, Bianca Rd, Falcone L, d'Angelo I, Ungaro F, Quaglia F, Carnuccio R, Sorrentino R.

Am J Respir Cell Mol Biol. 2013 Aug;49(2):288-95. doi: 10.1165/rcmb.2012-0473OC.

PMID:
23590300
[PubMed - indexed for MEDLINE]
14.

Inhibition of anastomotic intimal hyperplasia using a chimeric decoy strategy against NFkappaB and E2F in a rabbit model.

Miyake T, Aoki M, Morishita R.

Cardiovasc Res. 2008 Sep 1;79(4):706-14. doi: 10.1093/cvr/cvn139. Epub 2008 May 31.

PMID:
18515844
[PubMed - indexed for MEDLINE]
Free Article
15.

Transfection of nuclear factor-kappaB decoy oligodeoxynucleotide protects against ischemia/reperfusion injury in a rat epigastric flap model.

Uemura T, Tsujii M, Akeda K, Iino T, Satonaka H, Hasegawa M, Sudo A.

J Gene Med. 2012 Nov;14(11):623-31. doi: 10.1002/jgm.2677.

PMID:
23080520
[PubMed - indexed for MEDLINE]
16.

Nuclear factor kappa B decoy oligodeoxynucleotides prevent endotoxin-induced fatal liver failure in a murine model.

Ogushi I, Iimuro Y, Seki E, Son G, Hirano T, Hada T, Tsutsui H, Nakanishi K, Morishita R, Kaneda Y, Fujimoto J.

Hepatology. 2003 Aug;38(2):335-44.

PMID:
12883477
[PubMed - indexed for MEDLINE]
17.

Potential protective effect of nuclear factor-κB decoy oligodeoxynucleotides on endotoxin-induced liver injury.

Li JD, Peng Y, Li Q, Xiao JW, Gong JP, Liu ZJ.

Transplant Proc. 2011 Dec;43(10):3613-7. doi: 10.1016/j.transproceed.2011.10.046.

PMID:
22172814
[PubMed - indexed for MEDLINE]
18.

Regression of intracranial aneurysms by simultaneous inhibition of nuclear factor-κB and Ets with chimeric decoy oligodeoxynucleotide treatment.

Aoki T, Kataoka H, Nishimura M, Ishibashi R, Morishita R, Miyamoto S.

Neurosurgery. 2012 Jun;70(6):1534-43; discussion 1543. doi: 10.1227/NEU.0b013e318246a390. Erratum in: Neurosurgery. 2012 Aug;71(2):502.

PMID:
22186838
[PubMed - indexed for MEDLINE]
19.

Nuclear factor-kappaB decoy oligodeoxynucleotides prevent acute lung injury in mice with cecal ligation and puncture-induced sepsis.

Matsuda N, Hattori Y, Jesmin S, Gando S.

Mol Pharmacol. 2005 Apr;67(4):1018-25. Epub 2004 Dec 2.

PMID:
15576632
[PubMed - indexed for MEDLINE]
Free Article
20.

Systemic administration of ribbon-type decoy oligodeoxynucleotide against nuclear factor κB and ets prevents abdominal aortic aneurysm in rat model.

Miyake T, Aoki M, Osako MK, Shimamura M, Nakagami H, Morishita R.

Mol Ther. 2011 Jan;19(1):181-7. doi: 10.1038/mt.2010.208. Epub 2010 Sep 28.

PMID:
20877343
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk